
Montelukast (10mg) + Levocetirizine (5mg)
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medical applications
Monteneo-LC Tablet is a combination medication consisting of 5mg of Levocetirizine, a potent H1 receptor antagonist, and 10mg of Montelukast, a selective and potent Cysteinyl Leukotriene (Cyst-LT1) antagonist. This dual-action formulation provides comprehensive relief from various allergic and respiratory symptoms. The Levocetirizine component effectively blocks the H1 receptors, thereby reducing histamine-induced itching, pruritus, and allergic reactions, while the Montelukast component inhibits the Cyst-LT1 receptor, thereby preventing bronchoconstriction, airway hyperresponsiveness, and inflammation. As a result, Monteneo-LC Tablet provides effective treatment for conditions such as seasonal allergic rhinitis, chronic idiopathic urticaria, and mild to moderate asthma. Its once-daily dosing regimen and predictable efficacy profile make it an attractive option for patients seeking comprehensive relief from these conditions.
How to use Monteneo-LC Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Monteneo-LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Monteneo-LC Tablet. Please consult your doctor.
High Risk
Monteneo-LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Monteneo-LC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Monteneo-LC Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Monteneo-LC Tablet may be needed. Please consult your doctor. Limited information is available on the use of Monteneo-LC Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Monteneo-LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Monteneo-LC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monteneo-LC Tablet may be needed. Please consult your doctor. Use of Monteneo-LC Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Monteneo-LC Tablet

Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medical applications
Monteneo-LC Tablet is a combination medication consisting of 5mg of Levocetirizine, a potent H1 receptor antagonist, and 10mg of Montelukast, a selective and potent Cysteinyl Leukotriene (Cyst-LT1) antagonist. This dual-action formulation provides comprehensive relief from various allergic and respiratory symptoms. The Levocetirizine component effectively blocks the H1 receptors, thereby reducing histamine-induced itching, pruritus, and allergic reactions, while the Montelukast component inhibits the Cyst-LT1 receptor, thereby preventing bronchoconstriction, airway hyperresponsiveness, and inflammation. As a result, Monteneo-LC Tablet provides effective treatment for conditions such as seasonal allergic rhinitis, chronic idiopathic urticaria, and mild to moderate asthma. Its once-daily dosing regimen and predictable efficacy profile make it an attractive option for patients seeking comprehensive relief from these conditions.
How to use Monteneo-LC Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Monteneo-LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Monteneo-LC Tablet. Please consult your doctor.
High Risk
Monteneo-LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Monteneo-LC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Monteneo-LC Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Monteneo-LC Tablet may be needed. Please consult your doctor. Limited information is available on the use of Monteneo-LC Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Monteneo-LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Monteneo-LC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monteneo-LC Tablet may be needed. Please consult your doctor. Use of Monteneo-LC Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Monteneo-LC Tablet















